Bio-Gate: Update on the HIPrevision clinical trial for HyProtect™-coated hip revision implants
Study protocol published in the internationally recognized peer-reviewed journal Trials (Springer Nature/BMC) Multicenter, randomized controlled trial at 10 centers in Germany, Poland, and Spain involving over 200 patients Further step in the clinical development of HyProtect™-coated revision implants Nuremberg, Germany, June 23, 2026 – Bio-Gate AG (ISIN DE000BGAG981), a leading provider of innovative healthcare technologies, […]
Read Article







